tiprankstipranks
Century Therapeutics (IPSC)
NASDAQ:IPSC
US Market
Holding IPSC?
Track your performance easily

Century Therapeutics (IPSC) Ownership - Who Owns Century Therapeutics?

144 Followers

Century Therapeutics (IPSC) Ownership Overview

3.69%5.31%29.27%5.18%56.55%
29.27% Other Institutional Investors
5.18% ETFs
56.55% Public Companies and
Individual Investors
The ownership structure of Century Therapeutics (IPSC) stock is a mix of institutional, retail, and individual investors. Approximately 39.76% of the company’s stock is owned by Institutional Investors, 3.69% is owned by Insiders, and 56.55% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 05, 2024
xxxxxxxxxxxxx
$1260
Nov 05, 2024
Douglas Carr
Svp Finance & Operations
xxxxxxxxxxxxx
$21275
Sep 16, 2024
Daphne Quimi
Director
xxxxxxxxxxxxx
$7650
Aug 07, 2024
xxxxxxxxxxxxx
$1953

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,442,899Institution2.87%3,029,195
1,631,294Institution1.92%2,022,805
1,470,704Insider1.73%1,823,673
1,413,995Institution1.66%1,753,354
1,285,970Institution1.51%1,594,603
797,460Institution0.94%988,850
560,544Insider0.66%695,075
507,403Institution0.60%629,180
418,326Institution0.49%518,724
367,706Insider0.43%455,955

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,413,995Institution1.66%1,753,354
1,285,970Institution1.51%1,594,603
507,403Institution0.60%629,180
418,326Institution0.49%518,724
218,004Institution0.26%270,325
152,359Institution0.18%188,925
143,800Institution0.17%178,312
142,853Institution0.17%177,138
69,955Institution0.08%86,744
29,885Institution0.04%37,057

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,314,621Institution1.55%1,511,814
1,082,583Institution1.27%1,342,403
785,571Institution0.92%903,407
423,782Institution0.50%525,490
209,418Institution0.25%240,831
168,184Institution0.20%211,912
111,158Institution0.13%137,836
99,782Institution0.12%114,749
44,924Institution0.05%56,604
31,576Institution0.04%36,312

FAQ

Who Owns Century Therapeutics (IPSC)?
According to the latest TipRanks data, approximately 29.27% of the company's stock is held by institutional investors, 3.69% is held by insiders, and 56.55% is held by retail investors.
    What percentage of Century Therapeutics (IPSC) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 29.27% of Century Therapeutics (IPSC) stock is held by institutional investors.
      What percentage of Century Therapeutics (IPSC) stock is held by retail investors?
      According to the latest TipRanks data, approximately 56.55% of Century Therapeutics (IPSC) stock is held by retail investors.
        Who owns the most shares of Century Therapeutics (IPSC)?
        Vanguard owns the most shares of Century Therapeutics (IPSC).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis